PAVmed (PAVM) Depreciation and Depletion (2016 - 2022)

PAVmed's Depreciation and Depletion history runs 7 years deep, the most recent figure standing at $93000.0 for Q1 2022.

• On a quarterly basis, Depreciation and Depletion rose 675.0% year-over-year to $93000.0 in Q1 2022; TTM through Mar 2022 was $121000.0, a 278.12% increase from a year earlier, with the FY2025 full-year figure at $105000.0, down 83.57% from the prior year.
• Depreciation and Depletion climbed to $93000.0 in Q1 2022 per PAVM's latest filing, from $10000.0 in the prior quarter.
• Across five years, Depreciation and Depletion topped out at $93000.0 in Q1 2022 and bottomed at $1802.0 in Q2 2018.
• The 5-year median for Depreciation and Depletion is $3546.0 (2018), against an average of $10738.1.
• Across the five-year window, Depreciation and Depletion plunged 57.74% in 2018 and jumped 675.0% in 2022, its largest moves.
• Year by year, Depreciation and Depletion stood at $3546.0 in 2018, then climbed by 12.8% to $4000.0 in 2019, then surged by 50.0% to $6000.0 in 2020, then jumped by 66.67% to $10000.0 in 2021, then soared by 830.0% to $93000.0 in 2022.
• Per Business Quant, the three latest PAVM Depreciation and Depletion figures stand at $93000.0 (Q1 2022), $10000.0 (Q2 2021), and $12000.0 (Q1 2021).